Non-thiazolidinedione antihyperglycaemic agents. Part 3: the effects of stereochemistry on the potency of α-methoxy-β-phenylpropanoic acids-Reference-Cited by-同舟云学术

Non-thiazolidinedione antihyperglycaemic agents. Part 3: the effects of stereochemistry on the potency of α-methoxy-β-phenylpropanoic acids

Published:1999-05 Issue:5 Volume:7 Page:821-830
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Haigh David,Allen Graham,Birrell Helen C.,Buckle Derek R.,Cantello Barrie C.C.,Eggleston Drake S.,Haltiwanger R.Curtis,Holder Julie C.,Lister Carolyn A.,Pinto Ivan L.,Rami Harshad K.,Sime John T.,Smith Stephen A.,Sweeney John D.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference45 articles.

1. Reaven, G. M. Diabetes 1988, 37, 1595.

2. Moller, D. E.; Flier, J. S. N. Engl. J. Med. 1991, 325, 938.

3. DeFronzo, R. A. Diabetes 1988, 37, 667.

4. Warram, J. H.; Martin, B. C.; Krolewski, A. S.; Soeldner, J. S.; Kahn, C. R. Ann. Intern. Med. 1990, 113, 909.

5. Lillioja, S.; Mott, D. M.; Spraul, M., Ferraro, R.; Foley, J. E.; Ravussin, E.; Knowler, W. C.; Bennett, P. H.; Bogardus, C. N. Engl. J. Med. 1993, 329, 1988.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin sensitizers in 2023: lessons learned and new avenues for investigation;Expert Opinion on Investigational Drugs;2023-09-02

2. PPARγ-sparing thiazolidinediones as insulin sensitizers. Design, synthesis and selection of compounds for clinical development;Bioorganic & Medicinal Chemistry;2018-12

3. Anti-inflammatory Principles from Sarcandra glabra;Journal of Agricultural and Food Chemistry;2017-02-02

4. Enantioselective Synthesis of PPAR (Peroxisome Proliferator-Activated Receptors) Agonists and Antagonists;Current Topics in Medicinal Chemistry;2014-05-31

5. Insulin sensitizers in 2013: new insights for the development of novel therapeutic agents to treat metabolic diseases;Expert Opinion on Investigational Drugs;2013-09-27